This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
San Diego-based Avalon Ventures , a venture capital firm focused on early stage high tech, digital media, and life sciences firms, said today that it has closed on $200M in capital commitments for its latest fund. Avalon said that the fund, Avalon Ventures IX, LP, is the ninth and largest fund for the company.
La Jolla-based venture capital investor Avalon Ventures has just received a $103M commitment to a new, $300M fund, according to a regulatory filing by the firm. Avalon invests in both life sciences and technology companies, and invests in seed an dearly stage companies. READ MORE>>.
The latest numbers from the MoneyTree Report from PricewaterhouseCoopers, The National Venture Capital Association, and Thomson Reuters have tallied up just under a billion dollars in venture capital investments in the Southern California region in Q1 of this year, a very significant uptick from Q2 of 2011.
San Diego-based Chumby , which had developed Internet-connected, alarm-clock like devices and similar technology, has shut down, according to a report Friday. The Verge, which first reported the news, said that Chumby's employees are now working for Technicolor, and the firm is looking to sell off its technology. READ MORE>>.
San Diego-based Avelas Biosciences announced today that it has raised $6.85M in a Series B funding round, for the company''s technology for illuminating cancer cells. The company said the funding came from Avalon Ventures, and also included Torrey Pines Investment, WuXi AppTec, and an additional, un-named investor. READ MORE>>.
The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. The technology behind the Avelas product is based on research conducted at UC San Diego. in a Series B funding. READ MORE>>.
San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. The funding came from Avalon Ventures. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients.
and FAIL Blog web sites, apparently was spawned out of an introduction at last year's Twiistup technology conference, according to investor the Foundry Group. Along with Foundry, both Madrona Ventures and San Diego's Avalon Ventures were investors in the round. READ MORE>>.
Investments by venture capitalists in Southern California were up, both in terms of deals and dollars in Q2, according to the latest numbers from PricewaterhouseCoopers and the National Venture Capital Association (NVCA). Tags: venture capital pricewaterhousecoopers nvca finance moneytree thomson reuters. Los Angeles saw $407.2M
San Diego-based crowdsourced local sports information provider ScoreStream , led by technology vet Derrick Oien, says it has connected its information into Amazon Alexa. ScoreStream's venture backers include Intel Capital, Avalon Ventures, Sinclair Broadcasting, R/GA and Verizon Ventures. READ MORE>>.
San Diego-based Synthorx , a developer of protein therapeutics technology, said it has raised $10M in a Series B financing this morning. The funding was led by RA Capital Management, and also included Avalon Ventures and Correlation Ventures. RA Capital Management's Andrew Levin joins the company's board with the funding.
The latest numbers from the PricewaterhouseCoopers/National Venture capital Association MoneyTree survey, which is based on data from Thomson Reuters, tallies $738.34M invested in Southern California in Q4 of 2011. The amount is up from $528.0M raised in Q4 of 2010, and up from the $652M invested in the region last quarter.
According to E-Band, the round was led by Hercules Technology Growth Capital, and also included Avalon Ventures. San Diego-based E-Band Communications , a developer of millimeter-wave wireless transmission systems, said Wednesday that the firm has raised a Series C financing round.
The funding came from Divergent Ventures, along with existing investors Avalon Ventures. Bolt was most recently at Avamar Technologies, where he was CTO of the firm before its acquisition by EMC in 2006. The firm said the new funding brings its total raised to $5M. The firm is led by Rory Bolt. READ MORE>>.
Irvine-based Broadcom and San Diego-based Chumby are working together to integrate Chumby's technology into set top boxes, the firms announced this morning. According to the companies, the integration of that technology onto Broadcom's digital TV chips will allow users to personalize their user experience on Internet-connected TVs.
The startup--led by technology startup vet Derrick Oien--said the funding was led by Sinclair Digital Ventures, a division of Sinclair Broadcast Group. Also participating in the funding was Avalon Ventures, New Enterprise Associates, and angels, including Kevin Plank (Under Armour) and Paul Palmieri (Millennial Media). READ MORE>>.
in a Series A financing for the firm's biopharmaceuticals technology. According to the firm, the financing came from Avalon Ventures LLC. San Diego-based Zacharon Pharmaceutical said today that it has raised $3.5M The firm also said it has received more than $2.2M in National Institutes of Health (NIH) research grants.
The funding was led by Avalon Ventures and TPG Biotech, and also included Correlation Ventures and Osage University Partners. Enlibrium said the technology has been exclusively licensed from UCLA. San Diego-based Enlibrium announced Thursday that it has raised $15M in a Series A financing, to go towards cancer therapeutics.
The firm said the round was led by Cardinal partners, and also included Venrock and prior investor Avalon Ventures. Awarepoint develops real-time location systems (RTLS), which uses wireless RFID technology to monitor the location of hospital equipment, patients, and doctors.
San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups). Lilly Asia Ventures, Osage University Partners, and Vivo Capital joined in the deal, according to a statement from Avalon. Bregua Corp.,
PricewaterhouseCoopers and the National Venture Capital Association (NVCA) released their 2008 Q4 MoneyTree Report this evening, reporting that $28.3 Clean Technology saw a 52 percent increase in terms of dollars, and 16 percent growth in deal volume over 2007, reaching an investment level of $4.1 billion in 818 deals, down from $7.3
and San Diego’s Avalon Ventures. Inbio Ventures, a venture capital management company, represented Pharmstandard in the deal. Avalon Ventures founded Avelas, and has housed the startup with other Avalon biotech startups at its COI Pharmaceuticals R&D facility in San Diego.
After Chumby, I was EIR for Avalon Ventures, and was looking at a couple of different opportunities, ranging from 3D printing, to Machine-to-Machine communications, medical IT, and sports there. It's actually nice that there is a shortage of capital for sports startups. Derrick Oien: We started ScoreStream three years ago.
After Chumby, I was EIR for Avalon Ventures, and was looking at a couple of different opportunities, ranging from 3D printing, to Machine-to-Machine communications, medical IT, and sports there. It's actually nice that there is a shortage of capital for sports startups. Derrick Oien: We started Sportstream three years ago.
Synthorx, which is working to develop cancer and autoimmune therapies using technology that allows it to expand the genetic alphabet, raised $131 million in an upsized IPO on Thursday. The company sold more than 11.9 million shares at $11 apiece. million additional shares are available for its underwriters to purchase.
Synthorx, the San Diego synthetic biology startup that expanded the number of DNA base pairs with two synthetic nucleotides, said today it has raised $10 million in a Series B financing round led by RA Capital Management, the Boston life sciences hedge fund. Existing investors Avalon Ventures and Correlation Ventures joined in the round.
Downtown Works is a co-working space for technology startups that opened last month in a completely renovated office building at the corner of India and West B streets. The co-working space occupies the top floor and mezzanine of the building, and includes shared desks, offices, conference rooms, kitchen, and rooftop deck. It’s really cool.”.
After demonstrating in 2016 how its synthetic biology technology could produce new biologic drugs , San Diego’s Synthorx today revealed that its lead drug candidate is an improved version of interleukin-2, an anti-cancer drug of intense commercial interest in the 1980s.
The Connected Car , where automotive and technology (outside of vehicle performance and earth saving “greenness”) collide. At the time, the Camry was a staple car, so he worked to create the Sienna mini-van and Avalon luxury sedan off the Camry platform. That’s just how advertising was at the time. .
It was during this time, she recalled, when Bock met Kevin Kinsella of San Diego’s Avalon Ventures. In 1998, Nelsen recalled, “People thought we were crazy” to apply optics to genotyping when Affymetrix and its solid phase arrays represented the dominant technology at the time. They had a lot of fun.”.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content